Real-world outcomes of axicabtagene ciloleucel in adult patients with primary mediastinal B-cell lymphoma

被引：18
|
作者：
Crombie, Jennifer L. [1 ]
Nastoupil, Loretta J. [2 ]
Redd, Robert [1 ]
Tang, Kevin [3 ]
Shouse, Geoffrey [4 ]
Herrera, Alex F. [4 ]
Chow, Victor A. [5 ]
Shadman, Mazyar [5 ]
Puglianini, Omar Castaneda [6 ]
Saucier, Anna [1 ]
Jacobson, Caron A. [1 ]
Armand, Philippe [1 ]
Simmons, Gary [6 ]
机构：
[1] Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02115 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Baylor Sch Med, Houston, TX USA
[4] City Hope Canc Ctr, Duarte, CA USA
[5] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle Canc Alliance, Seattle, WA 98195 USA
[6] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA
来源：
BLOOD ADVANCES | 2021年 / 5卷 / 18期
关键词：
EXPRESSION; DIAGNOSIS;
D O I：
10.1182/bloodadvances.2021004880
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3563 / 3567
页数：5
相关论文
共 50 条
  • [1] Real-world and clinical trial outcomes in large B-cell lymphoma with axicabtagene ciloleucel across race and ethnicity
    Locke, Frederick L.
    Siddiqi, Tanya
    Jacobson, Caron A.
    Ghobadi, Armin
    Ahmed, Sairah
    Miklos, David B.
    Perales, Miguel -Angel
    Munoz, Javier
    Fingrut, Warren B.
    Pennisi, Martina
    Gauthier, Jordan
    Shadman, Mazyar
    Gowda, Lohith
    Mirza, Abu-Sayeef
    Abid, Muhammad Bilal
    Hong, Sanghee
    Majhail, Navneet S.
    Kharfan-Dabaja, Mohamed A.
    Khurana, Arushi
    Badar, Talha
    Lin, Yi
    Bennani, N. Nora
    Herr, Megan M.
    Hu, Zhen-Huan
    Wang, Hai -Lin
    Baer, Anjani
    Baro, Elande
    Miao, Harry
    Spooner, Clare
    Xu, Hairong
    Pasquini, Marcelo C.
    BLOOD, 2024, 143 (26) : 2722 - 2734
  • [2] Axicabtagene ciloleucel in vivo expansion and treatment outcome in aggressive B-cell lymphoma in a real-world setting
    Ayuk, Francis A.
    Berger, Carolina
    Badbaran, Anita
    Zabelina, Tatjana
    Sonntag, Tanja
    Riecken, Kristoffer
    Geffken, Maria
    Wichmann, Dominic
    Frenzel, Christian
    Thayssen, Guenther
    Zeschke, Silke
    Kroeger, Nicolaus
    Fehse, Boris
    BLOOD ADVANCES, 2021, 5 (11) : 2523 - 2527
  • [3] REAL-WORLD SAFETY AND EFFECTIVENESS OF AXICABTAGENE CILOLEUCEL IN PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA.
    Wang, M.
    Datta, D.
    Rubin, B.
    Patel, A.
    Vashisht, R.
    Belov, A.
    Whitaker, B.
    Anderson, S.
    Butte, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 109 : S50 - S50
  • [4] A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma
    Looka, Andrew
    Qualls, David A.
    Matthews, Daniel
    Redd, Robert A.
    Sakellis, Christopher
    Duffy, Caitlyn
    Dela Cruz, Jamie
    Saucier, Anna
    Armand, Philippe
    Crombie, Jennifer L.
    Fisher, David C.
    Jacobsen, Eric D.
    Kim, Austin I.
    Lacasce, Ann S.
    Merryman, Reid W.
    Parry, Erin M.
    Jacobson, Caron A.
    BLOOD ADVANCES, 2025, 9 (03) : 455 - 462
  • [5] Axicabtagene Ciloleucel in Large B-Cell Lymphoma
    Zhao, Wei-Li
    Wu, De-pei
    Hu, Yu
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (12): : 1152 - 1153
  • [6] Real-world outcomes of axicabtagene ciloleucel (Axi-cel) for the treatment of large B-cell lymphoma (LBCL) by race and ethnicity.
    Locke, Frederick L.
    Siddiqi, Tanya
    Jacobson, Caron Alyce
    Ghobadi, Armin
    Ahmed, Sairah
    Miklos, David Bernard
    Perales, Miguel-Angel
    Munoz, Javier
    Logan, Brent
    Hu, Zhen-Huan
    Miao, Harry H.
    Singh, Kanwarjit
    Shah, Jina
    Xu, Hairong
    Pasquini, Marcelo C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [7] Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
    Tove Wästerlid
    Sverker Hasselblom
    Joel Joelsson
    Caroline E. Weibull
    Georgios Rassidakis
    Birgitta Sander
    Karin E. Smedby
    Blood Cancer Journal, 11
  • [8] Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study
    Wasterlid, Tove
    Hasselblom, Sverker
    Joelsson, Joel
    Weibull, Caroline E.
    Rassidakis, Georgios
    Sander, Birgitta
    Smedby, Karin E.
    BLOOD CANCER JOURNAL, 2021, 11 (05)
  • [9] Checkpoint Inhibition before Axicabtagene Ciloleucel Cell Therapy in Primary Mediastinal B-Cell Lymphoma (PMBCL) Treated in Real Life Setting
    Chiappella, Annalisa
    Dodero, Anna
    Guidetti, Anna
    Bagnoli, Filippo
    Aragona, Vanessa
    Barbui, Anna Maria
    Bramanti, Stefania
    Carrabba, Matteo Giovanni
    Sora, Federica
    Zinzani, Pierluigi
    Monfrini, Chiara
    Carniti, Cristiana
    Corradini, Paolo
    BLOOD, 2020, 136
  • [10] Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States
    Jacobson, Caron A.
    Locke, Frederick L.
    Ma, Long
    Asubonteng, Julius
    Hu, Zhen-Huan
    Siddiqi, Tanya
    Ahmed, Sairah
    Ghobadi, Armin
    Miklos, David Bernard
    Lin, Yi
    Perales, Miguel-Angel
    Lunning, Matthew Alexander
    Herr, Megan M.
    Hill, Brian T.
    Ganguly, Siddhartha
    Dong, Hua
    Nikiforow, Sarah
    Hooper, Michele
    Kawashima, Jun
    Xu, Hairong
    Pasquini, Marcelo C.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (09): : 581.e1 - 581.e8
12345